Natalie Sacks, Chief Medical Officer at Harpoon Therapeutics, Inc. (HARP), sold 48,300 shares at $13.21 ($640K) on 2019-10-15, disclosed to the SEC on 2019-10-16.
Open-market sale of $640k HARP by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.27 | 12,452 | $165K | 25.8% |
| 2 | $13.27 | 12,452 | $165K | 25.8% |
| 3 | $13.21 | 11,698 | $155K | 24.2% |
| 4 | $13.21 | 11,698 | $155K | 24.2% |
| Total | $13.24 avg | 48,300 | $640K | 100% |
| Filing → |
| HARP | SELL | 2020-04-17 | $18K | — | Filing → |
| HARP | SELL | 2020-04-15 | $110K | — | Filing → |
| HARP | SELL | 2020-04-08 | $15K | — | Filing → |